Shenzhen YHLO Biotech Co., Ltd. (SHA:688575)
China · Delayed Price · Currency is CNY 15.01
+0.17 (1.15%)
At close: Jan 23, 2026
Shenzhen YHLO Biotech Revenue
Shenzhen YHLO Biotech had revenue of 478.27M CNY in the quarter ending September 30, 2025, with 10.25% growth. This brings the company's revenue in the last twelve months to 1.90B, up 0.13% year-over-year. In the year 2024, Shenzhen YHLO Biotech had annual revenue of 2.01B, down -2.02%.
Revenue (ttm)
1.90B
Revenue Growth
+0.13%
P/S Ratio
4.50
Revenue / Employee
1.13M
Employees
1,678
Market Cap
8.58B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.01B | -41.48M | -2.02% |
| Dec 31, 2023 | 2.05B | -1.93B | -48.42% |
| Dec 31, 2022 | 3.98B | 2.80B | 237.95% |
| Dec 31, 2021 | 1.18B | 178.89M | 17.91% |
| Jan 1, 2021 | 999.01M | 121.65M | 13.87% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shinva Medical Instrument | 9.58B |
| Sinocare | 4.71B |
| Cofoe Medical Technology | 3.13B |
| Guangzhou Wondfo Biotech Co.,Ltd | 2.57B |
| Qingdao Haier Biomedical Co.,Ltd | 2.26B |
| Edan Instruments | 1.90B |
| INKON Life Technology | 1.69B |
| Shanghai Sanyou Medical | 512.33M |